Germany · Delayed Price · Currency is EUR Heidelberg Pharma AG Statistics
Total Valuation
ETR:HPHA has a market cap or net worth of EUR 118.83 million. The enterprise value is 93.95 million.
| Market Cap | 118.83M |
| Enterprise Value | 93.95M |
Important Dates
The last earnings date was Wednesday, July 15, 2026.
| Earnings Date | Jul 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ETR:HPHA has 46.78 million shares outstanding. The number of shares has increased by 0.33% in one year.
| Current Share Class | 46.78M |
| Shares Outstanding | 46.78M |
| Shares Change (YoY) | +0.33% |
| Shares Change (QoQ) | -3.03% |
| Owned by Insiders (%) | 2.31% |
| Owned by Institutions (%) | 0.73% |
| Float | 9.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.96 |
| PB Ratio | -8.36 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.62 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.29
| Current Ratio | 5.29 |
| Quick Ratio | 3.78 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.00 |
| Interest Coverage | -11,718.25 |
Financial Efficiency
Return on equity (ROE) is -1,539.85% and return on invested capital (ROIC) is -1,042.27%.
| Return on Equity (ROE) | -1,539.85% |
| Return on Assets (ROA) | -42.58% |
| Return on Invested Capital (ROIC) | -1,042.27% |
| Return on Capital Employed (ROCE) | -93.75% |
| Weighted Average Cost of Capital (WACC) | 8.49% |
| Revenue Per Employee | 181,590 |
| Profits Per Employee | -807,385 |
| Employee Count | 41 |
| Asset Turnover | 0.14 |
| Inventory Turnover | 0.08 |
Taxes
In the past 12 months, ETR:HPHA has paid 1.48 million in taxes.
| Income Tax | 1.48M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.95% in the last 52 weeks. The beta is 0.77, so ETR:HPHA's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -37.95% |
| 50-Day Moving Average | 2.61 |
| 200-Day Moving Average | 2.83 |
| Relative Strength Index (RSI) | 50.99 |
| Average Volume (20 Days) | 3,155 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ETR:HPHA had revenue of EUR 7.45 million and -33.10 million in losses. Loss per share was -0.71.
| Revenue | 7.45M |
| Gross Profit | 6.51M |
| Operating Income | -37.25M |
| Pretax Income | -31.63M |
| Net Income | -33.10M |
| EBITDA | -36.85M |
| EBIT | -37.25M |
| Loss Per Share | -0.71 |
Balance Sheet
The company has 24.93 million in cash and 45,985 in debt, with a net cash position of 24.88 million or 0.53 per share.
| Cash & Cash Equivalents | 24.93M |
| Total Debt | 45,985 |
| Net Cash | 24.88M |
| Net Cash Per Share | 0.53 |
| Equity (Book Value) | -14.22M |
| Book Value Per Share | -0.30 |
| Working Capital | 30.68M |
Cash Flow
In the last 12 months, operating cash flow was -24.80 million and capital expenditures -62,894, giving a free cash flow of -24.86 million.
| Operating Cash Flow | -24.80M |
| Capital Expenditures | -62,894 |
| Depreciation & Amortization | 405,129 |
| Net Borrowing | -123,164 |
| Free Cash Flow | -24.86M |
| FCF Per Share | -0.53 |
Margins
| Gross Margin | 87.49% |
| Operating Margin | -500.35% |
| Pretax Margin | -424.80% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ETR:HPHA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.33% |
| Shareholder Yield | -0.33% |
| Earnings Yield | -27.86% |
| FCF Yield | -20.92% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 7, 2017. It was a forward split with a ratio of 1.0464082038.
| Last Split Date | Nov 7, 2017 |
| Split Type | Forward |
| Split Ratio | 1.0464082038 |
Scores
ETR:HPHA has an Altman Z-Score of -11.4 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -11.4 |
| Piotroski F-Score | 2 |